This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gao, M. Articles by Vogt, P. K. Search for Related Content PubMed PubMed Citation Articles by Gao, M. Articles by Vogt, P. K.

Differential and Antagonistic Effects of v-Jun and c-Jun¹

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037

We compared the ability of cellular and viral Jun (c-Jun and v-Jun) to transactivate target genes. c-Jun and v-Jun bind specifically to 12-O-tetradecanoylphorbol-13-acetate responsive elements [TREs, also called activator protein 1 (AP-1) motifs]. However, whereas c-Jun activates TRE-controlled promoters, v-Jun represses them. Cotransfection of the two Jun proteins reduces c-Jun-dependent transactivation. The expression of the endogenous c-jun gene, regulated through a promoter-proximal AP-1-binding site, is repressed in v-Jun-transformed chicken embryo fibroblasts. It is suggested that an M_r, 18,000 v-Jun peptide prominent in v-Jun-transformed cells acts as a transdominant-negative regulator of AP-1 activity and of c-jun expression. In contrast to the results with TRE sites, both v-Jun and c-Jun activate transcription through the human T-cell leukemia virus type I 21-bp repeat which contains a sequence homologous to the cyclic AMP responsive element. However, full-length Jun proteins bind to this site only with low affinity, and binding of the truncated v-Jun was barely detectable. These observations show that the oncogenic viral form of Jun differs from the cellular version in promoter preference and on certain promoters acts as an antagonist to c-Jun.

¹ This work was supported by USPHS Grant CA 42564.

² Present address: Veterans Affairs Medical Center-San Diego and Department of Medicine, University of California, San Diego, CA 92161.

³ Present address: Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, Scotland.

Received 6/20/96. Accepted 7/12/96.

This article has been cited by other articles:

				S. Loebrich and E. Nedivi The Function of Activity-Regulated Genes in the Nervous System Physiol Rev, October 1, 2009; 89(4): 1079 - 1103. [Abstract] [Full Text] [PDF]

				K. N. Farrow, A. P. Bradford, J. J. Tentler, and A. Gutierrez-Hartmann Structural and Functional Analysis of the Differential Effects of c-Jun and v-Jun on Prolactin Gene Expression Mol. Endocrinol., October 1, 2004; 18(10): 2479 - 2490. [Abstract] [Full Text] [PDF]

				M. H. Gao, T. Tang, T. Guo, S. Q. Sun, J. R. Feramisco, and H. K. Hammond Adenylyl Cyclase Type VI Gene Transfer Reduces Phospholamban Expression in Cardiac Myocytes via Activating Transcription Factor 3 J. Biol. Chem., September 10, 2004; 279(37): 38797 - 38802. [Abstract] [Full Text] [PDF]

				D. B. Parkinson, Z. Dong, H. Bunting, J. Whitfield, C. Meier, H. Marie, R. Mirsky, and K. R. Jessen Transforming Growth Factor beta (TGFbeta ) Mediates Schwann Cell Death In Vitro and In Vivo: Examination of c-Jun Activation, Interactions with Survival Signals, and the Relationship of TGFbeta -Mediated Death to Schwann Cell Differentiation J. Neurosci., November 1, 2001; 21(21): 8572 - 8585. [Abstract] [Full Text] [PDF]

				W. Clark, E. J. Black, A. MacLaren, U. Kruse, N. LaThangue, P. K. Vogt, and D. A. F. Gillespie v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity Mol. Cell. Biol., April 1, 2000; 20(7): 2529 - 2542. [Abstract] [Full Text]

				P. K. Vogt, M. Aoki, I. Bottoli, H.-W. Chang, S.-l. Fu, A. Hecht, J. S. Iacovoni, B.-H. Jiang, and U. Kruse A Random Walk in Oncogene Space: The Quest for Targets Cell Growth Differ., December 1, 1999; 10(12): 777 - 784. [Full Text]

				S.-l. Fu, I. Bottoli, M. Goller, and P. K. Vogt Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation PNAS, May 11, 1999; 96(10): 5716 - 5721. [Abstract] [Full Text] [PDF]

				U. Kruse, J. S. Iacovoni, M. E. Goller, and P. K. Vogt Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera PNAS, November 11, 1997; 94(23): 12396 - 12400. [Abstract] [Full Text] [PDF]

				D.-Y. Jin, H. Teramoto, C.-Z. Giam, R. F. Chun, J. S. Gutkind, and K.-T. Jeang A Human Suppressor of c-Jun N-terminal Kinase 1 Activation by Tumor Necrosis Factor alpha J. Biol. Chem., October 10, 1997; 272(41): 25816 - 25823. [Abstract] [Full Text] [PDF]